Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond.

Saved in:
Bibliographic Details
Title: Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond.
Authors: Schürmann H; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; Bridge Institute of Experimental Tumor Therapy (BIT) and Division of Solid Tumor Translational Oncology (DKTK), West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site Essen, a Partnership Between German Cancer Research Center (DKFZ) and University Hospital Essen, Essen, Germany., Park W; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA.; David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, New York, NY, USA., O'Kane GM; St. Vincent's University Hospital and School of Medicine, University College Dublin, Dublin, Republic of Ireland., Sciortino C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Reichert M; Center for Translational Pancreatic Cancer Research, TUM School of Medicine and Health, Department of Clinical Medicine, Clinical Department for Internal Medicine II, TUM University Hospital, Technical University of Munich, Munich, Germany.; Center for Organoid Systems (COS), Munich Institute of Biomedical Engineering (MIBE), Technical University Munich (TUM), Garching, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, A Partnership Between German Cancer Research Center (DKFZ) and TUM University Hospital, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany., Olive KP; Department of Medicine, Division of Digestive and Liver Diseases, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, USA.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA., Pretzell I; West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Westphalen CB; Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. cwestpha@med.lmu.de.; German Cancer Consortium (DKTK), Partner Site Munich, a Partnership Between German Cancer Research Center (DKFZ) and University Hospital of the LMU Munich, Munich, Germany. cwestpha@med.lmu.de.; Comprehensive Cancer Center (CCC Munich LMU), LMU University Hospital Munich, Munich, Germany. cwestpha@med.lmu.de.
Source: Targeted oncology [Target Oncol] 2026 Jul 20. Date of Electronic Publication: 2026 Jul 20.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer-Verlag France Country of Publication: France NLM ID: 101270595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1776-260X (Electronic) Linking ISSN: 17762596 NLM ISO Abbreviation: Target Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1776-260X
DOI:10.1007/s11523-026-01236-x